Chief Medical Officer of Cybin, responsible for medical governance and leading Cybin's programs through clinical development.

Trained as a psychiatrist and pharmaceutical physician with over 20 years of clinical and drug development experience.

Successfully progressed numerous candidate drugs through preclinical development and early phase clinical trials to proof-of-concept studies.

Experienced in leading global teams overseeing development of novel medications across a range of psychiatric indications including treatment resistant depression, narcolepsy, anxiety, schizophrenia, bipolar disorder and substance use disorders.